Survival curves were plotted to compare patient outcomes in different expression levels of HNF4α and IL-1R1 and we found a reduction of survival time in patients with high co-expression levels of HNF4α and IL-1R1 in different types of gastric cancer (Figure 6C and 6D). This evidence concerns the gene HNF4A and gastric cancer.